16,747 Shares in Chemed Corporation $CHE Purchased by Deutsche Bank AG

Key Points

• Deutsche Bank acquired 16,747 Chemed shares worth approximately $7.8 million, joining other institutional investors; institutions collectively own 95.85% of the stock.
• Chemed reported quarterly EPS of $6.06, exceeding the $5.60 consensus estimate, while revenue rose 8.8% year over year to $673.25 million. The company issued fiscal 2026 EPS guidance of $25.00–$25.75.
• Chemed increased its quarterly dividend from $0.60 to $0.70 per share, implying an annualized dividend of $2.80 and a 0.5% yield; analysts maintain a consensus “Hold” rating with a $530.75 target price.

Deutsche Bank AG acquired a new position in shares of Chemed Corporation (NYSE:CHE - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 16,747 shares of the company's stock, valued at approximately $7,800,000. Deutsche Bank AG owned about 0.13% of Chemed at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Commonwealth Equity Services LLC boosted its holdings in shares of Chemed by 3.1% in the 4th quarter. Commonwealth Equity Services LLC now owns 734 shares of the company's stock worth $314,000 after purchasing an additional 22 shares during the period. Cim LLC increased its position in shares of Chemed by 1.1% during the 3rd quarter. Cim LLC now owns 2,139 shares of the company's stock valued at $958,000 after purchasing an additional 24 shares during the last quarter. Eukles Asset Management raised its holdings in Chemed by 0.4% during the 4th quarter. Eukles Asset Management now owns 6,056 shares of the company's stock valued at $2,591,000 after buying an additional 25 shares during the period. MassMutual Private Wealth & Trust FSB raised its holdings in Chemed by 65.3% during the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 81 shares of the company's stock valued at $38,000 after buying an additional 32 shares during the period. Finally, EverSource Wealth Advisors LLC raised its holdings in Chemed by 9.4% during the 1st quarter. EverSource Wealth Advisors LLC now owns 406 shares of the company's stock valued at $153,000 after buying an additional 35 shares during the period. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

Chemed Trading Up 0.1%

Shares of NYSE CHE opened at $541.33 on Monday. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.89 and a current ratio of 0.91. The business's 50 day moving average price is $499.24 and its 200-day moving average price is $446.50. Chemed Corporation has a fifty-two week low of $365.20 and a fifty-two week high of $557.00. The company has a market cap of $7.08 billion, a price-to-earnings ratio of 27.19, a PEG ratio of 2.05 and a beta of 0.51.

Chemed (NYSE:CHE - Get Free Report) last posted its quarterly earnings data on Tuesday, July 28th. The company reported $6.06 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $5.60 by $0.46. Chemed had a return on equity of 31.77% and a net margin of 10.60%.The company had revenue of $673.25 million during the quarter, compared to analysts' expectations of $665.04 million. During the same quarter in the previous year, the business earned $4.27 EPS. Chemed's revenue was up 8.8% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. On average, sell-side analysts expect that Chemed Corporation will post 23.18 earnings per share for the current year.

Chemed Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 3rd. Stockholders of record on Monday, August 17th will be given a dividend of $0.70 per share. This represents a $2.80 annualized dividend and a dividend yield of 0.5%. This is a positive change from Chemed's previous quarterly dividend of $0.60. The ex-dividend date is Monday, August 17th. Chemed's dividend payout ratio is 14.06%.

Analyst Ratings Changes

CHE has been the subject of several recent analyst reports. Bank of America reaffirmed a "neutral" rating on shares of Chemed in a research note on Wednesday, July 29th. Weiss Ratings raised shares of Chemed from a "hold (c-)" rating to a "hold (c)" rating in a research note on Friday, July 17th. Royal Bank Of Canada raised their target price on shares of Chemed from $436.00 to $548.00 and gave the stock a "sector perform" rating in a report on Thursday, July 30th. Zacks Research upgraded shares of Chemed from a "strong sell" rating to a "hold" rating in a report on Monday, April 27th. Finally, Oppenheimer lifted their price target on shares of Chemed from $500.00 to $590.00 and gave the stock an "outperform" rating in a research note on Friday, July 31st. One research analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of $530.75.

Insider Transactions at Chemed

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the business's stock in a transaction on Monday, August 3rd. The shares were sold at an average price of $539.51, for a total transaction of $1,079,020.00. Following the completion of the sale, the chief executive officer directly owned 70,418 shares of the company's stock, valued at approximately $37,991,215.18. The trade was a 2.76% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Andrea R. Lindell sold 1,347 shares of the company's stock in a transaction dated Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total transaction of $602,553.51. Following the completion of the transaction, the director owned 4,578 shares in the company, valued at approximately $2,047,876.74. The trade was a 22.73% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 3,537 shares of company stock worth $1,782,654. 3.33% of the stock is currently owned by insiders.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corporation (NYSE:CHE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source